Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) EBT Margin (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of EBT Margin data on record, last reported at 28.11% in Q4 2025.

  • For Q4 2025, EBT Margin rose 2002.0% year-over-year to 28.11%; the TTM value through Dec 2025 reached 8.33%, up 891.0%, while the annual FY2025 figure was 8.33%, 891.0% up from the prior year.
  • EBT Margin reached 28.11% in Q4 2025 per ORGO's latest filing, up from 14.03% in the prior quarter.
  • Across five years, EBT Margin topped out at 28.11% in Q4 2025 and bottomed at 29.74% in Q1 2025.
  • Average EBT Margin over 5 years is 3.88%, with a median of 7.31% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 3626bps in 2021, then crashed -2579bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 14.77% in 2021, then crashed by -49bps to 7.58% in 2022, then tumbled by -124bps to 1.8% in 2023, then surged by 549bps to 8.1% in 2024, then soared by 247bps to 28.11% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 28.11% in Q4 2025, 14.03% in Q3 2025, and 11.72% in Q2 2025.